in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Aurobindo Pharma reports rise in API sales
12:51 PM MST | February 12, 2014 | Deepti Ramesh
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December 2013, compared with the year-ago quarter, to 7.44 billion Indian rupees ($120 million). Earnings figures for the API business have not been disclosed. Aurobindo is one of the global leaders in APIs. Cephalosporin accounted for Rs2.17 billion of Aurobindo’s total API sales of in the fiscal third quarter, semisynthetic penicillin accounted for Rs2.58 billion, and nonbetalactam...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee